Novel PET Imaging Agent Accurately IDs Clear Cell Renal Cancers

(MedPage Today) -- An investigational PET imaging agent -- zirconium-89 (89Zr)-deferoxamine (DFO)-girentuximab -- identified clear cell renal cell carcinoma (ccRCC) with high sensitivity and specificity, according to results from the phase...
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news